A Federal Bankruptcy Court judge on Thursday approved Edward Lampert’s bid through his ESL Investments hedge fund to purchase the struggling retailer’s assets for $5.2 billion.
The Association for Accessible Medicines has told members of Congress that the Hatch-Waxman Integrity Act of 2019 would decrease patient access to generics and biosimilars.
The pilot will inform the development of the enhanced electronic, interoperable track-and-trace system for industry set to go into effect in 2023 as part of the Drug Supply Chain Security Act, the agency said.
The Food and Drug Administration has cleared Lupin's generic Adcirca, which had a market value of about $474.3 million for the year ended December 2018.
The National Association of Chain Drug Stores and the National Community Pharmacists Association praised a letter from senators to Health and Human Services secretary Alex Azar urging action on DIR fee reform and an end to unfair practices to pharmacies.
The Trump Administration's 2019 National Drug Control Strategy is consistent with the National Association of Chain Drug Stores' public policy recommendations, the organization said.
The National Association of Chain Drug Stores' Regional Chain Conference 2019 began with a focus on its Access Agenda and the role that pharmacies play in patients' lives and in health care.
The bill comes as teen misuse of DXM is on the decline, a trend the Consumer Healthcare Products Association partially attributes to state-level age restrictions that have been passed in 17 states.
